ArticleScientific reports2026
Development of a questionnaire to assess the medication literacy of patients receiving oral anticancer drugs.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication literacy is particularly important for patients undergoing oral anticancer therapy, as this treatment involves additional challenges and responsibilities compared to intravenous chemotherapy. The aim of this study was to develop a questionnaire to measure the medication literacy of patients receiving oral anticancer therapy. Following semi-structured interviews and an expert focus group, a first draft of the questionnaire was developed. The draft consisted of two parts, each containing four dimensions. Part A of the questionnaire measured patients' self-assessed medication literacy, whereas Part B measured their functional medication literacy. After this, both parts of the draft questionnaire were evaluated by conducting a patient survey in oncology practices and community pharmacies. Based on the results of factor analyses, the questionnaire was adapted and finalised. Lastly, the criterion-related validity of the final questionnaire was tested using linear regression analysis, with the aim of investigating its possible influence on quality of life and patient enablement. Factor analysis resulted in a questionnaire that contained 27 items across 7 dimensions. A total of 307 patients was included in the patient survey. Patients achieved an average of 36.7 out of 50 points in Part A and 11.7 out of 17 points in Part B of the final instrument, with higher scores indicating better results. Part A was found to be positively associated with quality of life and patient enablement. While Part A exhibited sound psychometric criteria, Part B still lacked sufficient internal consistency. In conclusion, we developed the first medication literacy questionnaire designed completely from scratch for cancer patients receiving oral anticancer therapy. The part on self-assessed medication literacy could be used as a patient-relevant endpoint or for identifying patients in need of further support with their medication. The part on functional medication literacy needs further refinement. This project is registered in the German Clinical Trials Register (no. DRKS00034341, registration date: 2024-06-03; https://drks.de/search/en/trial/DRKS00034341 ).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.